CANNABIS POLAND AB ZY-10 (8TE) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.304x

Based on the latest financial reports, CANNABIS POLAND AB ZY-10 (8TE) has a cash flow conversion efficiency ratio of -0.304x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-463.42K ≈ $-541.78K USD) by net assets (€1.52 Million ≈ $1.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 8TE days of operational coverage to measure how many days the company can operate on defensive assets alone.

CANNABIS POLAND AB ZY-10 - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how CANNABIS POLAND AB ZY-10's cash flow conversion efficiency has evolved over time, based on yearly financial data.

CANNABIS POLAND AB ZY-10 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CANNABIS POLAND AB ZY-10 ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
AVRO INDIA LIMITED NSE:AVROIND	-0.036x
Ortin Global Limited NSE:ORTINGLOBE	-0.627x
Innovation Beverage Group Limited NASDAQ:IBG	-0.413x
Tivic Health Systems Inc NASDAQ:TIVC	-0.453x
Ion Energy Ltd V:ION	-0.208x
Foncière Euris SA PA:EURS	-0.116x
TNL Mediagene Ordinary Shares NASDAQ:TNMG	-2.001x
Airesis SA SW:AIRE	0.045x

Annual Cash Flow Conversion Efficiency for CANNABIS POLAND AB ZY-10 (2021–2025)

The table below shows the annual cash flow conversion efficiency of CANNABIS POLAND AB ZY-10 from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see CANNABIS POLAND AB ZY-10 market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€1.52 Million ≈ $1.78 Million	€-2.17 Million ≈ $-2.54 Million	-1.426x	-138.71%
2024-12-31	€3.54 Million ≈ $4.14 Million	€-2.11 Million ≈ $-2.47 Million	-0.598x	+37.85%
2023-12-31	€1.36 Million ≈ $1.58 Million	€-1.30 Million ≈ $-1.52 Million	-0.961x	+13.37%
2022-12-31	€321.96K ≈ $376.41K	€-357.28K ≈ $-417.70K	-1.110x	+42.68%
2021-12-31	€480.84K ≈ $562.15K	€-930.97K ≈ $-1.09 Million	-1.936x	--

About CANNABIS POLAND AB ZY-10

F:8TE Germany Drug Manufacturers - Specialty & Generic

Market Cap

$1.82 Million

€1.56 Million EUR

Market Cap Rank

#30215 Global

#2654 in Germany

Share Price

€0.03

Change (1 day)

-5.45%

52-Week Range

€0.02 - €0.07

All Time High

€0.69